Ipsen (IPSEF) Short Interest


IPSEF Ipsen SA IPSEF
95 GF Score
Price $113.13
GF Value $92.81
! 7 Warning Signs
View Full Analysis

What is Ipsen Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

IPSEF vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipsen Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's Short Interest distribution charts can be found below:

* The bar in red indicates where Ipsen's Short Interest falls into.


IPSEF
95GF Score
Ipsen SA IPSEF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipsen (IPSEF) Overvalued in 2026?

Based on GuruFocus' analysis, Ipsen stock appears to be overvalued. The current stock price of $113.13 is trading 21.9% above its estimated GF Value™ of $92.81.

Key valuation signals for IPSEF:

  • Short Interest:
  • GF Value™: $92.81 vs. price of $113.13 (21.9% above fair value)
  • GF Score™: 95/100 with 7 warning signs

No single metric tells the full story. See the IPSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipsen Business Description

Address 70 rue Balard, Paris, FRA, 75015
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
95GF Score

Get the complete analysis for IPSEF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$113.13
Price
$92.81
GF Value